Comparison of quetiapine, olanzapine, and risperidone in schizophrenia

被引：4
|
作者：
Sacchetti, E
Valsecchi, P
Regini, C
Galluzzo, A
Cacciani, P
Agrimi, E
Mencacci, C
机构：
[1] Univ Brescia, Sch Med, Chair Psychiat, I-25121 Brescia, Italy
[2] Univ Brescia, Spedali Civili, Psychiat Unit, I-25121 Brescia, Italy
[3] Brescia Spedali Civili, Dept Mental Hlth, Brescia, Italy
[4] Azienda Osped, Ist Ospitalieri Cremona, Dept Mental Hlth, Cremona, Italy
[5] Osped Fatebenefratelli & Oftalm Milan, Dept Mental Hlth, Milan, Italy
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷
关键词：
D O I：
10.1016/S0924-977X(04)80342-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [41] Post authorization safety study comparing quetiapine to risperidone and olanzapine
    Heintjes, Edith M.
    Overbeek, Jetty A.
    Penning-van Beest, Fernie J. A.
    Brobert, Gunnar
    Herings, Ron M. C.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2016, 31 (04) : 304 - 312
  • [42] Comparison of risperidone, olanzapine and quetiapine in relation to body weight, serum blood glucose and prolactin levels
    Chaudhry, H. R.
    Niaz, S.
    Arshad, N.
    Peracha, F.
    Ayub, A.
    Mufti, K. A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S241 - S241
  • [43] Oral risperidone, olanzapine and quetiapine versus haloperidol in psychotic agitation
    Villari, Vincenzo
    Rocca, Paola
    Fonzo, Valeria
    Montemagni, Cristiana
    Pandullo, Pasquale
    Bogetto, Filippo
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (02): : 405 - 413
  • [44] Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
    Erik Johnsen
    Rune A Kroken
    Tore Wentzel-Larsen
    Hugo A Jørgensen
    BMC Psychiatry, 10
  • [45] Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone
    Johnsen, Erik
    Kroken, Rune A.
    Wentzel-Larsen, Tore
    Jorgensen, Hugo A.
    BMC PSYCHIATRY, 2010, 10
  • [46] Cognitive benefits of quetiapine versus risperidone in schizophrenia
    Spellmann, I
    Riedel, M
    Müller, N
    Strassnig, M
    Douhet, A
    Dehning, S
    Möller, HJ
    PHARMACOPSYCHIATRY, 2005, 38 (05) : 278 - 278
  • [47] Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone
    Manu, Peter
    Correll, Christoph U.
    Wampers, Martien
    van Winkel, Ruud
    Yu, Weiping
    Shiffeldrim, Daphna
    Kane, John M.
    De Hert, Marc
    SCHIZOPHRENIA RESEARCH, 2013, 143 (2-3) : 358 - 362
  • [48] Post Authorization Safety Study Comparing Quetiapine to Risperidone and Olanzapine
    Heintjes, Edith M.
    Overbeek, Jetty A.
    Penning-van Beest, Fernie J. A.
    Brobert, Gunnar
    Herings, Ron M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 90 - 90
  • [49] Comparison of atypicals in first-episode psychosis: a randomized, 52-week comparison of olanzapine, quetiapine, and risperidone
    Lieberman, J
    McEvoy, JP
    Perkins, D
    Hamer, RH
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S526 - S526
  • [50] Risperidone and quetiapine for treatment-resistant schizophrenia
    Polana, P
    Roveyaz, E
    Colotto, A
    EUROPEAN PSYCHIATRY, 2002, 17 : 104S - 104S
12345